BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37954593)

  • 41. The association of peripheral immune markers with brain cortical thickness and surface area in South African people living with HIV.
    Williams ME; Joska JA; Amod AR; Paul RH; Stein DJ; Ipser JC; Naudé PJW
    J Neurovirol; 2020 Dec; 26(6):908-919. PubMed ID: 32661895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections.
    Vanham G; Kestens L; Gigase P; Colebunders R; Vandenbruaene M; Brijs L; Ceuppens JL
    Clin Exp Immunol; 1990 Oct; 82(1):3-9. PubMed ID: 2208794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells
    Meziane O; Salahuddin S; Pham TNQ; Farnos O; Pagliuzza A; Olivenstein R; Thomson E; Alexandrova Y; Orlova M; Schurr E; Ancuta P; Haddad É; Chomont N; Cohen EA; Jenabian MA; Costiniuk CT
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus-Specific CD4+ T-cell Responses and CMV-IgG Levels Are Associated With Neurocognitive Impairment in People Living With HIV.
    Ballegaard V; Pedersen KK; Pedersen M; Brændstrup P; Kirkby N; Buus AS; Ryder LP; Gerstoft J; Nielsen SD
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):117-125. PubMed ID: 29781883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.
    Hunt PW; Sinclair E; Rodriguez B; Shive C; Clagett B; Funderburg N; Robinson J; Huang Y; Epling L; Martin JN; Deeks SG; Meinert CL; Van Natta ML; Jabs DA; Lederman MM
    J Infect Dis; 2014 Oct; 210(8):1228-38. PubMed ID: 24755434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients.
    Gazzola L; Bellistri GM; Tincati C; Ierardi V; Savoldi A; Del Sole A; Tagliabue L; d'Arminio Monforte A; Marchetti G
    J Transl Med; 2013 Feb; 11():51. PubMed ID: 23448662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.
    Psomas C; Younas M; Reynes C; Cezar R; Portalès P; Tuaillon E; Guigues A; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Marin G; Nagot N; Sotto A; Eliaou JF; Sabatier R; Reynes J; Corbeau P
    EBioMedicine; 2016 Jun; 8():265-276. PubMed ID: 27428436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.
    Meziane O; Alexandrova Y; Olivenstein R; Dupuy FP; Salahuddin S; Thomson E; Orlova M; Schurr E; Ancuta P; Durand M; Chomont N; Estaquier J; Bernard NF; Costiniuk CT; Jenabian MA
    J Immunol; 2021 Feb; 206(3):641-651. PubMed ID: 33318292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.
    Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y
    Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serial evaluation of percentage of activated T-lymphocytes in peripheral blood of human immunodeficiency virus infected individuals as a prognostic marker.
    Shakoor Z
    Saudi Med J; 2003 Jun; 24(6):632-6. PubMed ID: 12847593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
    Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
    AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.
    Choi BS; Park YK; Lee JS
    Clin Exp Immunol; 2002 Jan; 127(1):137-44. PubMed ID: 11882044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
    Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults.
    Zhang Z; Chew GM; Shikuma CM; Gangcuangco LMA; Souza SA; Shiramizu B; Nakamoto BK; Gong T; Mannem SR; Mitchell BI; Kallianpur KJ; Ndhlovu LC; Chow DC
    HIV Clin Trials; 2018 Oct; 19(5):172-176. PubMed ID: 30422099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
    Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
    Front Immunol; 2019; 10():2185. PubMed ID: 31572392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.